TY - JOUR
T1 - Knowledge of cervical cancer prevention and human papillomavirus among women with HIV
AU - Massad, L. Stewart
AU - Evans, Charlesnika T.
AU - Wilson, Tracey E.
AU - Goderre, Johanna L.
AU - Hessol, Nancy A.
AU - Henry, Donna
AU - Colie, Christine
AU - Strickler, Howard D.
AU - Levine, Alexandra M.
AU - Watts, D. Heather
AU - Weber, Kathleen M.
N1 - Funding Information:
Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS) Collaborative Study Group with centers (Principal Investigators) at New York City/Bronx Consortium (Kathryn Anastos); Brooklyn, NY (Howard Minkoff); Washington DC Metropolitan Consortium (Mary Young); The Connie Wofsy Study Consortium of Northern California (Ruth Greenblatt); Los Angeles County/Southern California Consortium (Alexandra Levine); Chicago Consortium (Mardge Cohen); Data Coordinating Center (Stephen Gange). The WIHS is funded by the National Institute of Allergy and Infectious Diseases ( UO1-AI-35004 , UO1-AI-31834 , UO1-AI-34994 , UO1-AI-34989 , UO1-AI-34993 , and UO1-AI-42590 ) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development ( UO1-HD-32632 ). The study is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131 ). H.D. Strickler was supported by NCI R01 CA85178-01 . The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
PY - 2010/4
Y1 - 2010/4
N2 - Objective: To assess knowledge of and attitudes towards human papillomavirus (HPV), Pap testing, and the HPV vaccine. Methods: In a multicenter U.S. cohort study, women with the human immunodeficiency virus (HIV) and at-risk comparison women completed 44-item standardized self-report questionnaires exploring their knowledge of cervical cancer prevention, HPV, and HPV vaccination. Results were correlated with demographic variables, measures of education and attention, and medical factors. Data were clustered using principal component analysis. Significant associations were assessed in multivariable models. Results: Among 1588 women, HIV seropositive women better understood facts about cervical cancer prevention and HPV than seronegative women, but both had substantial knowledge deficits. Almost all women considered Pap testing important, although 53% of HIV seropositive and 48% of seronegative women considered cervical cancer not preventable (P = 0.21). Only 44% of HIV seropositive women knew Paps assess the cervix, versus 42% of HIV seronegative women (P = 0.57). Both groups understood that HPV causes genital warts and cervical cancer (67% of HIV seropositive vs. 55% of seronegative women, P = 0.002). About half of both groups considered HPV vaccination extremely important for cervical cancer prevention. HIV seronegative women were more likely to report learning of HPV vaccination through advertising than from clinicians (81% vs. 64%, P < 0.0001). Conclusion: High risk women need effective education about cervical cancer prevention, HPV, and HPV vaccination.
AB - Objective: To assess knowledge of and attitudes towards human papillomavirus (HPV), Pap testing, and the HPV vaccine. Methods: In a multicenter U.S. cohort study, women with the human immunodeficiency virus (HIV) and at-risk comparison women completed 44-item standardized self-report questionnaires exploring their knowledge of cervical cancer prevention, HPV, and HPV vaccination. Results were correlated with demographic variables, measures of education and attention, and medical factors. Data were clustered using principal component analysis. Significant associations were assessed in multivariable models. Results: Among 1588 women, HIV seropositive women better understood facts about cervical cancer prevention and HPV than seronegative women, but both had substantial knowledge deficits. Almost all women considered Pap testing important, although 53% of HIV seropositive and 48% of seronegative women considered cervical cancer not preventable (P = 0.21). Only 44% of HIV seropositive women knew Paps assess the cervix, versus 42% of HIV seronegative women (P = 0.57). Both groups understood that HPV causes genital warts and cervical cancer (67% of HIV seropositive vs. 55% of seronegative women, P = 0.002). About half of both groups considered HPV vaccination extremely important for cervical cancer prevention. HIV seronegative women were more likely to report learning of HPV vaccination through advertising than from clinicians (81% vs. 64%, P < 0.0001). Conclusion: High risk women need effective education about cervical cancer prevention, HPV, and HPV vaccination.
KW - Cervical cancer prevention
KW - HIV in women
KW - HPV
KW - Health education
KW - Pap test
UR - http://www.scopus.com/inward/record.url?scp=77949310953&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77949310953&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2009.12.030
DO - 10.1016/j.ygyno.2009.12.030
M3 - Article
C2 - 20106513
AN - SCOPUS:77949310953
VL - 117
SP - 70
EP - 76
JO - Gynecologic Oncology
JF - Gynecologic Oncology
SN - 0090-8258
IS - 1
ER -